Summary
Tolmesoxide is a new, direct-acting vasodilator drug for use in the management of both hypertension and cardiac failure. In 6 essential hypertensives inadequately controlled by combined β-blocker and diuretic therapy (average supine blood pressure 178/103 mm Hg) the addition of tolmesoxide (300–900 mg daily) was associated with a significant improvement in blood pressure control (average supine blood pressure 161/89 mmHg). The effect of food on the pharmacokinetics and pharmacodynamics of tolmesoxide have also been studied because, particularly at higher doses, the drug has been associated with upper gastrointestinal upset and it has been empirically recommended that it be taken with food. The blood pressure and heart rate responses were not significantly different when tolmesoxide was taken fasting or with food. Food resulted in a significant reduction in the peak plasma tolmesoxide concentration (2.14 µg/ml compared to 2.97 µg/ml) and a significant increase in the time to reach peak plasma concentration (1.67 h compared to 0.63 h). Although there was no impairment of its hypotensive effect, food significantly altered the pharmacokinetics of tolmesoxide and may therefore be useful in reducing the gastrointestinal disturbance associated with its use. In the treatment of inadequately controlled hypertension, tolmesoxide has a limited role as an alternative vasodilator.
Similar content being viewed by others
References
Collier JG, Lorge RE, Robinson BF (1978) Comparison of effects of tolmesoxide (RX71107), diazoxide, hydralazine, prazosin, glyceryl trinitrate and sodium nitroprusside on forearm arteries and dorsal hand veins of man. Br J Clin Pharmacol 5: 35–44
Silas JH, Phillips FC, Freestone S, Tucker GT, Ramsay LE (1981) A clinical and pharmacokinetic evaluation of tolmesoxide in hypertensive patients. Eur J Clin Pharmacol 19: 113–118
McGarry K, O'Boyle CP, Fitzgerald D, Kelly JG, Hogarth J, O'Malley K (1980) Tolmesoxide a new vasodilator in refractory heart failure. World Conference on Clinical Pharmacology and Therapeutics. McMillan, London, p 927
Lloyd-Jones JG, Henson RA, Nichols JD, Greenslade D, Clifford JM (1981) Pharmacokinetics of intravenous and oral tolmesoxide. Eur J Clin Pharmacol 19: 119–125
Doxey JC (1978) Tolmesoxide, a drug that lowers blood pressure by a direct relaxant effect on vascular smooth muscle. Br J Pharmacol 63: 111–118
O'Boyle CP, Laher M, Kelly JG, O'Brien ET, O'Malley K (1980) Acute antihypertensive effects of tolmesoxide, a new vasodilator. World Conference on Clinical Pharmacology and Therapeutics. McMillan, London, p 931
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Elliott, H.L., Meredith, P.A., McLean, K. et al. The effect of food on the pharmacokinetics and pharmacodynamics of tolmesoxide in essential hypertensives. Eur J Clin Pharmacol 21, 287–291 (1982). https://doi.org/10.1007/BF00637615
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00637615